Logo image of BTO

JOHN HANCOCK FINANCIAL OPP (BTO) Stock Overview

USA - NYSE:BTO - US4097352060

34.33 USD
+0.41 (+1.21%)
Last: 10/20/2025, 8:04:01 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BTO. BTO was compared to 0 industry peers in the Unkown industry. BTO may be in some trouble as it scores bad on both profitability and health. BTO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

BTO had positive earnings in the past year.
BTO had a positive operating cash flow in the past year.
BTO Yearly Net Income VS EBIT VS OCF VS FCFBTO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 50M 100M

1.2 Ratios

Industry RankSector Rank
ROA 19.43%
ROE 23.37%
ROIC 0.92%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BTO Yearly ROA, ROE, ROICBTO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 5 10 15 20

1.3 Margins

Industry RankSector Rank
OM 34.56%
PM (TTM) 580%
GM 41.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BTO Yearly Profit, Operating, Gross MarginsBTO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 100 200 300 400 500

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for BTO remains at a similar level compared to 1 year ago.
BTO has a better debt/assets ratio than last year.
BTO Yearly Shares OutstandingBTO Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 5M 10M 15M
BTO Yearly Total Debt VS Total AssetsBTO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 200M 400M 600M 800M

2.2 Solvency

BTO has an Altman-Z score of 3.59. This indicates that BTO is financially healthy and has little risk of bankruptcy at the moment.
The Debt to FCF ratio of BTO is 2.95, which is a good value as it means it would take BTO, 2.95 years of fcf income to pay off all of its debts.
BTO has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 2.95
Altman-Z 3.59
ROIC/WACCN/A
WACCN/A
BTO Yearly LT Debt VS Equity VS FCFBTO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.20 indicates that BTO should not have too much problems paying its short term obligations.
A Quick Ratio of 1.20 indicates that BTO should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 1.2
BTO Yearly Current Assets VS Current LiabilitesBTO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 500K 1M 1.5M 2M

More info and screens

1

3. Growth

3.1 Past

BTO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.64%, which is quite good.
Looking at the last year, BTO shows a small growth in Revenue. The Revenue has grown by 8.00% in the last year.
EPS 1Y (TTM)18.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104%
Revenue 1Y (TTM)8%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.69%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BTO Yearly Revenue VS EstimatesBTO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 5M 10M 15M 20M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 4.38, the valuation of BTO can be described as very cheap.
BTO's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.69.
Industry RankSector Rank
PE 4.38
Fwd PE N/A
BTO Price Earnings VS Forward Price EarningsBTO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 15.45
EV/EBITDA N/A
BTO Per share dataBTO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.67%, BTO is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.34, BTO pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.67%

5.2 History

BTO has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
BTO Yearly Dividends per shareBTO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

31.29% of the earnings are spent on dividend by BTO. This is a low number and sustainable payout ratio.
DP31.29%
EPS Next 2YN/A
EPS Next 3YN/A
BTO Yearly Income VS Free CF VS DividendBTO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2023 2024 50M 100M
BTO Dividend Payout.BTO Dividend Payout, showing the Payout Ratio.BTO Dividend Payout.PayoutRetained Earnings

More info and screens

JOHN HANCOCK FINANCIAL OPP

NYSE:BTO (10/20/2025, 8:04:01 PM)

34.33

+0.41 (+1.21%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-21 2025-08-21
Earnings (Next)02-23 2026-02-23
Inst Owners20.53%
Inst Owner Change-0.09%
Ins Owners0.04%
Ins Owner Change0%
Market Cap679.73M
Analysts0
Price TargetN/A
Short Float %0.09%
Short Ratio0.55
Dividend
Industry RankSector Rank
Dividend Yield 7.67%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP31.29%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-Date09-12 2025-09-12 (0.65)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 4.38
Fwd PE N/A
P/S 25.18
P/FCF 15.45
P/OCF 15.45
P/B 1.01
P/tB 1.01
EV/EBITDA N/A
EPS(TTM)7.83
EY22.81%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.22
FCFY6.47%
OCF(TTM)2.22
OCFY6.47%
SpS1.36
BVpS33.84
TBVpS33.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 19.43%
ROE 23.37%
ROCE 1.17%
ROIC 0.92%
ROICexc 0.92%
ROICexgc 0.92%
OM 34.56%
PM (TTM) 580%
GM 41.15%
FCFM 162.96%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 2.95
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.31
Cash Conversion N/A
Profit Quality 28.1%
Current Ratio 1.2
Quick Ratio 1.2
Altman-Z 3.59
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y18.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.42%
OCF growth 3YN/A
OCF growth 5YN/A